Swiss National Bank - TETRAPHASE PHARMACEUTICALS I ownership

TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 102 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q1 2016. The put-call ratio across all filers is 0.33 and the average weighting 0.1%.

Quarter-by-quarter ownership
Swiss National Bank ownership history of TETRAPHASE PHARMACEUTICALS I
ValueSharesWeighting
Q1 2016$206,000
-44.9%
46,200
+23.9%
0.00%
-100.0%
Q4 2015$374,000
+34.5%
37,3000.0%0.00%0.0%
Q3 2015$278,000
-81.6%
37,300
+16.9%
0.00%
-75.0%
Q2 2015$1,513,000
+31.6%
31,900
+1.6%
0.00%
+33.3%
Q1 2015$1,150,000
+5.7%
31,400
+14.6%
0.00%
-25.0%
Q4 2014$1,088,00027,4000.00%
Other shareholders
TETRAPHASE PHARMACEUTICALS I shareholders Q1 2016
NameSharesValueWeighting ↓
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
HUNTINGTON NATIONAL BANK 1$00.00%
View complete list of TETRAPHASE PHARMACEUTICALS I shareholders